Fig. 3From: Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer’s disease: post-hoc analysis of a randomized placebo-controlled studyMortality, cognitive, and functional outcomes of 24 months’ treatment with galantamine (dark green) or placebo (white or light green): a memantine nonusers and b memantine users. DAD Disability Assessment for Dementia, MMSE Mini-Mental State ExaminationBack to article page